Home/Publication/Stonebridge & STIC Revisit Alzheimer’s Drug Development
Stonebridge & STIC Revisit Alzheimer’s Drug Development 

14 Apr 2026

US$ 20.00

Stonebridge Ventures, STIC Ventures and Smilegate Investment were amongst those that have ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 17 Apr 2026...

Sony Ventures Corp, the corporate venture unit of Sony Group Corp (Sony), announced the launch of its Sony Innovation...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.